Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析

◆英語タイトル:Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0975
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Chong Kun Dang Pharmaceutical Corp (185750) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colors; aerosols; mat vaporizers and mosquito coils; and others. The company’s Chong Kun Dang Research Institute is characterized by three independent laboratories, namely, The New Drug Discovery Labs; The Technology Development Labs; and the Bio Research Labs. The company has presence in Japan, Korea, Vietnam and China. CKD Pharma is headquartered in Seoul, South Korea..

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Chong Kun Dang Pharmaceutical Corp – Key Facts
Chong Kun Dang Pharmaceutical Corp – Key Employees
Chong Kun Dang Pharmaceutical Corp – Major Products and Services
Chong Kun Dang Pharmaceutical Corp – History
Chong Kun Dang Pharmaceutical Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Chong Kun Dang Pharmaceutical Corp – Business Description
Chong Kun Dang Pharmaceutical Corp – SWOT Analysis
SWOT Analysis – Overview
Chong Kun Dang Pharmaceutical Corp – Strengths
Chong Kun Dang Pharmaceutical Corp – Weaknesses
Chong Kun Dang Pharmaceutical Corp – Opportunities
Chong Kun Dang Pharmaceutical Corp – Threats
Chong Kun Dang Pharmaceutical Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Chong Kun Dang Pharmaceutical Corp, Key Facts
Chong Kun Dang Pharmaceutical Corp, Key Employees
Chong Kun Dang Pharmaceutical Corp, Major Products and Services
Chong Kun Dang Pharmaceutical Corp, History
Chong Kun Dang Pharmaceutical Corp, Other Locations
Chong Kun Dang Pharmaceutical Corp, Key Competitors
Chong Kun Dang Pharmaceutical Corp, Ratios based on current share price
Chong Kun Dang Pharmaceutical Corp, Annual Ratios
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...1)
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...2)
Chong Kun Dang Pharmaceutical Corp, Interim Ratios
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Chong Kun Dang Pharmaceutical Corp, Performance Chart (2014 - 2018)
Chong Kun Dang Pharmaceutical Corp, Ratio Charts
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析
    NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Coeur Mining, Inc:企業のM&A・事業提携・投資動向
    Coeur Mining, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coeur Mining, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Solo Oil plc (SOLO):企業の財務・戦略的SWOT分析
    Summary Solo Oil Plc (Solo Oil), formerly Immersion Technologies International Plc, is an oil and gas exploration and production company that acquires, explores, develops and produces oil and gas resource development and production assets. The company's non operated oil and gas assets portfolio incl …
  • Peako Ltd (PKO):石油・ガス:M&Aディール及び事業提携情報
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is an oil and gas, and mineral exploration company. The company carries out the business of acquisition, exploration, and development of oil, natural gas, petroleum, and uranium properties. Its projects include SC6C Cadlao and Sunday Creek proj …
  • Boehringer Ingelheim GmbH:企業のM&A・事業提携・投資動向
    Boehringer Ingelheim GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boehringer Ingelheim GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Xellia Pharmaceuticals ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Xellia Pharmaceuticals ApS (Xellia), a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semi-synthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products …
  • Investment Technology Group, Inc.:企業の戦略・SWOT・財務分析
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Intralot S.A. (INLOT):企業の財務・戦略的SWOT分析
    Intralot S.A. (INLOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Great-West Lifeco Inc.:企業の戦略・SWOT・財務情報
    Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report Summary Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Harman International Industries Inc:企業の戦略的SWOT分析
    Harman International Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Flexion Therapeutics Inc (FLXN):企業の財務・戦略的SWOT分析
    Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Stereotaxis Inc (STXS):医療機器:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • Pets at Home Group Plc (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Group Plc (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ViroGates AS (VIRO):医療機器:M&Aディール及び事業提携情報
    Summary ViroGates AS (ViroGates) is a meditech company that offers prognostic products. The company develops a prognostic biomarker to make the suPAR test presented as a commercially available test. Its products comprise measures suPAR, quick triage and ELISA. ViroGates’ suparnostic products offer a …
  • Aquinox Pharmaceuticals Inc (AQXP):企業の財務・戦略的SWOT分析
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • Pakistan Petroleum Ltd (PPL):企業の財務・戦略的SWOT分析
    Pakistan Petroleum Ltd (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bio Blast Pharma Ltd (ORPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …
  • Harley-Davidson, Inc.:企業の戦略・SWOT・財務情報
    Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report Summary Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Biotron Ltd (BIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotron Ltd (Biotron) is a clinical stage biotechnology company which researches, develops and commercializes small molecules for the treatment of infectious diseases. Biotron’s core focus is to design and develop drugs that target viral ion channel proteins (viroporins). The company’s lead …
  • Lendlease Corporation Limited (LLC):企業の財務・戦略的SWOT分析
    Lendlease Corporation Limited (LLC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆